Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Cash from Financing Activities (2024 - 2025)

Carlsmed's Cash from Financing Activities history spans 2 years, with the latest figure at -$29000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 43.14% year-over-year to -$29000.0; the TTM value through Dec 2025 reached $104.5 million, changed N/A, while the annual FY2025 figure was $100.1 million, 71.16% up from the prior year.
  • Cash from Financing Activities reached -$29000.0 in Q4 2025 per CARL's latest filing, down from $90.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $90.7 million in Q3 2025 to a low of -$51000.0 in Q4 2024.